Lifestyle
- Regular physical activity
- Stress management
- Adequate sleep
Total Iron Binding Capacity · Totale Eisenbindungskapazität
TIBC quantifies the total capacity of blood proteins, primarily transferrin, to bind and transport iron.
Reference ranges may vary slightly depending on the laboratory and population. No significant sex-specific differences.
Total Iron Binding Capacity (TIBC) is a blood test that measures the maximum amount of iron that can be bound by proteins in the blood, primarily transferrin. This marker reflects the body's capacity to transport iron, which is crucial for various physiological functions, including oxygen transport and DNA synthesis. Clinically, TIBC is an important marker in the evaluation of iron metabolism and is often used in conjunction with other tests to diagnose iron deficiency anemia (IDA) and other disorders of iron metabolism. Elevated TIBC levels are typically associated with iron deficiency, as the body increases transferrin production to maximize iron transport. Conversely, low TIBC levels may indicate conditions such as chronic inflammation, malnutrition, or hemochromatosis, where iron is excessively stored in tissues. In the context of athletic performance and biohacking, maintaining optimal iron levels is crucial for endurance and overall energy metabolism. Researchers have found that lower TIBC levels are associated with longevity, suggesting that efficient iron utilization and minimal iron overload may contribute to a longer lifespan. However, TIBC values can be influenced by various factors, including nutritional status, inflammation, and liver function. It's important to consider these confounders when interpreting TIBC results. Additionally, fasting is not required for TIBC testing, but it is often performed alongside other iron studies that may require fasting for accurate results.
Klinische Bedeutung
Elevated TIBC values typically indicate iron deficiency, as the body increases transferrin production to enhance iron transport. Reduced TIBC values may suggest conditions such as chronic inflammation, malnutrition, or iron overload disorders like hemochromatosis.
Progressively rising TIBC values suggest worsening iron deficiency. Retesting is recommended every 3 months if outside the optimal range.
Progressively falling TIBC values may indicate improving iron status or the presence of chronic disease.
Re-test Interval
3 months if outside optimal range
Note:
Consult a physician before starting iron supplementation, especially if not diagnosed with iron deficiency.
Iron levels can vary throughout the day; morning tests are preferred.
Testing Frequency
Annually for individuals with known iron metabolism issues, or as part of a comprehensive anemia workup.
May affect
Current research suggests that reference ranges and optimal targets for total iron-binding capacity (TIBC) in diverse populations remain debated, particularly in relation to confounding factors such as inflammation and nutritional status. Researchers have not yet established the precise role of TIBC in differentiating types of microcytic anemia beyond iron deficiency. Additionally, clinical questions remain unanswered regarding the impact of TIBC variations on long-term outcomes in conditions like chronic kidney disease and their relationship with overall mortality.
1,330
Total Citations
12
Human/RCT
13.7
Avg. Influence
2025
Latest
Researchers developed a comprehensive Malnutrition-Inflammation Score (MIS) that includes total iron binding capacity as a component. They found that the MIS correlated significantly with hospitalization and mortality in maintenance hemodialysis patients, suggesting its potential as a predictor of clinical outcomes.
This study focused on the laboratory diagnosis of thalassemia, noting that both α- and β-thalassemia carriers present with microcytic parameters. Researchers emphasized the importance of iron status assessment to differentiate thalassemia from iron deficiency anemia.
Van Vranken Michele · American family physician · 2010
Researchers found that microcytosis is often an incidental finding, commonly caused by iron deficiency anemia and thalassemia trait. They emphasized the importance of serum ferritin measurement in evaluating microcytosis and identifying potential underlying blood loss.
Key findings
Murata Shunsuke, et al. · GeroScience · 2024
This study examined biomarker profiles in centenarians compared to shorter-lived individuals, finding that higher levels of iron and total cholesterol were associated with reaching age 100. Researchers observed that centenarians had more favorable biomarker values from age 65 onwards, suggesting potential genetic or lifestyle factors influencing longevity.
Key findings
This genome-wide meta-analysis examined iron status biomarkers and their effects on all-cause mortality. Researchers found evidence of harmful effects associated with increased serum iron and transferrin saturation, contributing to understanding the genetic factors influencing iron status.
Researchers found that iron deficiency anemia (IDA) is a prevalent condition affecting various populations, with laboratory features including low serum iron and increased total iron binding capacity. They emphasized the importance of identifying underlying causes for effective management. The review highlighted that approximately 2 billion people worldwide are affected by IDA.
This study highlighted that iron deficiency anemia is the most common type of microcytic anemia. Researchers noted that low serum ferritin is the best parameter for diagnosing iron deficiency, and emphasized the need to investigate underlying causes when anemia is identified.
Researchers investigated the causal relationship between iron status and functional outcomes after ischemic stroke. They found that higher levels of total iron binding capacity and serum iron were associated with poorer functional outcomes, suggesting a potential modifiable risk factor.
Researchers compared different methods for estimating total iron binding capacity (TIBC) and their correlation with serum transferrin levels. They found that the direct method of TIBC estimation showed a strong positive correlation with serum transferrin, making it the most reliable method.
This study assessed iron metabolism in nasopharyngeal carcinoma patients, finding lower levels of serum iron, TIBC, and transferrin compared to healthy controls. Researchers observed that the degree of iron deficiency correlated with tumor burden and metastasis.
Research publications about TIBC over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer